Features

Mind and Heart

(Page 3 of 3)

  • July/August 2007
  • By Anne Murphy

But Judelson brought more than the prin­ciples of engineering to her study of heart physiology; she also brought an intellectual rigor and adaptability that had been cultivated in her since her childhood in Patchogue, NY.

"My father loved to quiz us around the dinner table," recalls Judelson, who was the third of four children. "He'd say to us, 'Think of a number between 1 and 100 that can be divided by 11 and found in the living room." She solved that one as a kindergartner. And her talent for solving problems more complex than her father's piano puzzle would serve her well in clinical practice.

"I would see women coming in having trouble breathing, their heart muscles weakened," she says, recalling her days as a young doctor at ­Kaiser in Los Angeles. By combing through charts and pulling obscure papers from medical libraries, she began to decipher patterns suggesting that "these women had had heart attacks they never knew about."

That hypothesis launched a line of inquiry now in its third decade and a public-health campaign already in its second. Judelson says there's plenty more to be done in understanding microvascular disease in women, racial and ethnic variance in the incidence and morbidity of heart disease, and the effects of hormones and hormone therapies on women's hearts.

But she knows her work has made a difference: "I had a patient come in and ask me if I knew that heart disease was the number one cause of death among women. Or that 10 years ago, four out of five Americans didn't know that."

Judelson didn't tell her patient that she'd designed and popularized the survey she was citing. Instead, she said, "Tell me more about that." And the data gathering continued.

Print

Close Comments

To comment, please sign in or register

Forgot my password

doc_bev67

1 Comment

  • 1635 Days Ago
  • 08/24/2007

CHF in black women

My 41 yr. old daughter was diagnosed with CHF finally in Dec. 2005 after two pregnancies separated by only 2 years and while having Graves Disease. It was very difficulty to "force" her new cardiologist to treat her with the combination isosorbide/hydralazine recommended for African-American women at the time. She is stable right now praise GOD and her EF has improved 25% on this regimen. Thank you for this article on Dr. Judelson.  It reinforces my opinion on how important women physicians are to the research/clinical application of medicine today. Beverley JP Edwards, M.D.

Reply

Advertisement

MAGAZINE

Can We Build Tomorrow's Breakthroughs?

Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.

Videos

Meet 2011 TR35 Winner Jesse Robbins

More

Advertisement

Technology Review Lists

TR50

Our list of the 50 most innovative companies, including the following:

1366 Technologies

American Superconductor

Applied Materials

HTC

More

Advertisement
Advertisement